---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-006036"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2025-02-18T23:59:59+00:00"
generated_at: "2026-05-26T18:40:35.618971+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medifast Q4 revenue down 38% to $119M; EPS $0.07; guides Q1 loss

## Summary
- Q4 revenue $119M (-37.7% YoY); active earning coaches 27,100 (-34.1% YoY).
- Net income $0.8M ($0.07 diluted EPS); non-GAAP adjusted EPS $0.10.
- Full year 2024 revenue $602.5M (-43.8%); net income $2.1M ($0.19 EPS).
- Q1 2025 guidance: revenue $100-$120M, EPS loss $0.50 to $0.00 per share.
- Cash & investments $162.3M, no debt; cites GLP-1 market headwinds.

## SEC filing metadata
- accession: 0001628280-25-006036
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2025-02-18T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828025006036/0001628280-25-006036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828025006036/med-20250218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-006036
- JSON: https://secwatch.observer/filing/0001628280-25-006036.json
- Plain text: https://secwatch.observer/filing/0001628280-25-006036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.